SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Verastem Oncology Q4 EPS $(0.51) Down From $(0.37) YoY, Sales $3.617M Up From $1.21M YoY

Verastem Oncology (NASDAQ:VSTM) reported quarterly losses of $(0.51) per share. This is a 37.84 percent decrease over losses of $(0.37) per share from the same period last year. The company reported $3.617 million in

Benzinga · 03/11/2020 20:11

Verastem Oncology (NASDAQ:VSTM) reported quarterly losses of $(0.51) per share. This is a 37.84 percent decrease over losses of $(0.37) per share from the same period last year. The company reported $3.617 million in sales this quarter. This is a 198.93 percent increase over sales of $1.21 million the same period last year.